chr13-110181355-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001845.6(COL4A1):​c.2130G>A​(p.Pro710Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.356 in 1,612,120 control chromosomes in the GnomAD database, including 103,505 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.33 ( 8380 hom., cov: 31)
Exomes 𝑓: 0.36 ( 95125 hom. )

Consequence

COL4A1
NM_001845.6 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -5.01

Publications

23 publications found
Variant links:
Genes affected
COL4A1 (HGNC:2202): (collagen type IV alpha 1 chain) This gene encodes a type IV collagen alpha protein. Type IV collagen proteins are integral components of basement membranes. This gene shares a bidirectional promoter with a paralogous gene on the opposite strand. The protein consists of an amino-terminal 7S domain, a triple-helix forming collagenous domain, and a carboxy-terminal non-collagenous domain. It functions as part of a heterotrimer and interacts with other extracellular matrix components such as perlecans, proteoglycans, and laminins. In addition, proteolytic cleavage of the non-collagenous carboxy-terminal domain results in a biologically active fragment known as arresten, which has anti-angiogenic and tumor suppressor properties. Mutations in this gene cause porencephaly, cerebrovascular disease, and renal and muscular defects. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
COL4A1 Gene-Disease associations (from GenCC):
  • brain small vessel disease 1 with or without ocular anomalies
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Genomics England PanelApp
  • autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Orphanet
  • microangiopathy and leukoencephalopathy, pontine, autosomal dominant
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • familial porencephaly
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • pontine autosomal dominant microangiopathy with leukoencephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • retinal arterial tortuosity
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 13-110181355-C-T is Benign according to our data. Variant chr13-110181355-C-T is described in ClinVar as Benign. ClinVar VariationId is 258249.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-5.01 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.363 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001845.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL4A1
NM_001845.6
MANE Select
c.2130G>Ap.Pro710Pro
synonymous
Exon 29 of 52NP_001836.3P02462-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL4A1
ENST00000375820.10
TSL:1 MANE Select
c.2130G>Ap.Pro710Pro
synonymous
Exon 29 of 52ENSP00000364979.4P02462-1
COL4A1
ENST00000650424.2
c.2130G>Ap.Pro710Pro
synonymous
Exon 29 of 52ENSP00000497477.2A0A3B3ISV3
COL4A1
ENST00000933608.1
c.2130G>Ap.Pro710Pro
synonymous
Exon 29 of 51ENSP00000603667.1

Frequencies

GnomAD3 genomes
AF:
0.328
AC:
49626
AN:
151264
Hom.:
8368
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.239
Gnomad AMI
AF:
0.558
Gnomad AMR
AF:
0.357
Gnomad ASJ
AF:
0.343
Gnomad EAS
AF:
0.293
Gnomad SAS
AF:
0.369
Gnomad FIN
AF:
0.353
Gnomad MID
AF:
0.301
Gnomad NFE
AF:
0.367
Gnomad OTH
AF:
0.343
GnomAD2 exomes
AF:
0.351
AC:
87621
AN:
249938
AF XY:
0.352
show subpopulations
Gnomad AFR exome
AF:
0.241
Gnomad AMR exome
AF:
0.390
Gnomad ASJ exome
AF:
0.316
Gnomad EAS exome
AF:
0.293
Gnomad FIN exome
AF:
0.351
Gnomad NFE exome
AF:
0.360
Gnomad OTH exome
AF:
0.344
GnomAD4 exome
AF:
0.359
AC:
523824
AN:
1460740
Hom.:
95125
Cov.:
41
AF XY:
0.359
AC XY:
261125
AN XY:
726648
show subpopulations
African (AFR)
AF:
0.232
AC:
7755
AN:
33468
American (AMR)
AF:
0.388
AC:
17309
AN:
44630
Ashkenazi Jewish (ASJ)
AF:
0.320
AC:
8351
AN:
26118
East Asian (EAS)
AF:
0.257
AC:
10183
AN:
39670
South Asian (SAS)
AF:
0.373
AC:
32146
AN:
86174
European-Finnish (FIN)
AF:
0.356
AC:
18972
AN:
53362
Middle Eastern (MID)
AF:
0.266
AC:
1527
AN:
5750
European-Non Finnish (NFE)
AF:
0.366
AC:
406517
AN:
1111226
Other (OTH)
AF:
0.349
AC:
21064
AN:
60342
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
17618
35236
52854
70472
88090
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12868
25736
38604
51472
64340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.328
AC:
49665
AN:
151380
Hom.:
8380
Cov.:
31
AF XY:
0.329
AC XY:
24300
AN XY:
73876
show subpopulations
African (AFR)
AF:
0.239
AC:
9862
AN:
41248
American (AMR)
AF:
0.356
AC:
5431
AN:
15236
Ashkenazi Jewish (ASJ)
AF:
0.343
AC:
1190
AN:
3468
East Asian (EAS)
AF:
0.293
AC:
1502
AN:
5118
South Asian (SAS)
AF:
0.371
AC:
1770
AN:
4776
European-Finnish (FIN)
AF:
0.353
AC:
3684
AN:
10432
Middle Eastern (MID)
AF:
0.293
AC:
86
AN:
294
European-Non Finnish (NFE)
AF:
0.367
AC:
24902
AN:
67804
Other (OTH)
AF:
0.349
AC:
730
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1674
3347
5021
6694
8368
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
512
1024
1536
2048
2560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.345
Hom.:
12461
Bravo
AF:
0.324
Asia WGS
AF:
0.354
AC:
1230
AN:
3478
EpiCase
AF:
0.353
EpiControl
AF:
0.353

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
not specified (6)
-
-
2
Brain small vessel disease 1 with or without ocular anomalies (2)
-
-
2
not provided (2)
-
-
1
Autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
0.74
DANN
Benign
0.41
PhyloP100
-5.0
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs16975492; hg19: chr13-110833702; COSMIC: COSV65427049; API